PubHawk
March 2022 PMID 35318309

Antibody drug conjugate: the "biological missile" for targeted cancer therapy.

Zhiwen Fu, Shijun Li, Sifei Han, Chen Shi, Yu Zhang

Full text PDF Download social card

Mentions

75
Peak: 16 in Feb 2024
across 5 sources since Mar 2022

Extended reach

70,213
potential audience

Total likes

69

Video views

1,245

Mentions per month

Mar 2022 – Jan 2025

Where it's discussed

  • News41 articles
  • X / Twitter23 posts
  • Blogs5 articles
  • YouTube4 videos
  • Facebook2 posts

AI synopsis

What people are saying

Comments collectively reflect a recognition of ADCs as an innovative cancer treatment, with posts referencing related drugs and mentioning the broader implications for targeted therapy, using words like 'interesting' and 'clueless' to indicate varying degrees of engagement and impact.

AgreementModerate agreement

Most discussions acknowledge the importance of ADCs as a promising approach for targeted cancer therapy, reflecting a moderate consensus of support.

InterestModerate interest

Participants show curiosity, with some posts mentioning other research articles and specific drug examples, indicating a general interest in the topic.

EngagementModerate engagement

Several posts reference recent studies, note specific drugs, and engage in clarifying misconceptions, showing a moderate level of detailed engagement.

ImpactModerate impact

While some posts critique or correct misinformation, overall conversations highlight the growing significance of ADCs, suggesting they could influence future research directions.

Abstract in brief

  • Antibody drug conjugates (ADCs) are targeted cancer treatments made by attaching a potent drug to a monoclonal antibody, allowing precise delivery to cancer cells.
  • Since the approval of the first ADC in 2000, there have been 14 ADCs approved globally, with over 100 candidates in clinical trials, marking this as a rapidly advancing area of cancer therapy.
  • The review discusses the history, mechanism, key components, current approved drugs, ongoing clinical trials, challenges, and future directions for ADC development to enhance targeted cancer treatment options.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Ming "Tommy" Tang
@tangming2005 · X

Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 59 likes · 16 shares · 40,861 followers View post →
Vega Shah
@dr_alphalyrae · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 18,692 followers View post →
Sriganesh Srihari | Biomedical Data Science
@srigsri23 · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 2,108 followers View post →
Simona J Mlakar
@SimonaJurkovic · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 1,771 followers View post →
Creative-Biolabs
@creativebiolabs · X

Antibody drug conjugate: the “biological missile” for targeted cancer therapy. https://t.co/6l26FpwQRD

Mar 23, 2022 · 1,120 followers View post →
Federico Pietrocola
@FedericoPietr12 · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 795 followers View post →

All mentions

Pharmacology Insights
@PharmacoIns · X

Datopotamab-Deruxtecan for Breast Cancer: Learn how the combination works https://t.co/QWxbF5f3QD #oncology #BreastCancerResearch #Pharmacology #MedEd #MedicalEducation #FDA

Jan 30, 2025 · 11 followers View post →
Saleh Javaher
@SalehJavaher · X

@MaverickNY @genentech @WEHI_research Interesting points! I've noticed at least four other review articles that mention mirzotamab clezutoclax (ABBV-155) as either the last or first reference. https://t.co/H3NEMTk5tI https://t.co/6O6swk4TLM https://t.co/WDIkQ8kU0i https://t.co/hMxR4PiBNT

Sep 27, 2024 · 15 followers View post →
Naloxone
@KhalidW24675290 · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 23, 2024 · 16 shares · 154 followers View post →
Fredmoore Orosco, PhD
@fredmoorology · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 23, 2024 · 16 shares · 246 followers View post →
Koshi Kinoshita
@bruinwhitered · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 22, 2024 · 16 shares · 74 followers View post →
AngryPhDstudent❗️❗️❗️
@ONNESHA092 · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 22, 2024 · 16 shares · 188 followers View post →
Anam Kidwai
@kidwaiscience · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 433 followers View post →
KD- trainee assistant parwachani
@ShortMagus · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 344 followers View post →
Molly20256
@Molly20186 · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 83 followers View post →
Sriganesh Srihari | Biomedical Data Science
@srigsri23 · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 2,108 followers View post →
SportsBeast66Red
@SportsBeast66 · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 29 followers View post →
Simona J Mlakar
@SimonaJurkovic · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 1,771 followers View post →
Federico Pietrocola
@FedericoPietr12 · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 795 followers View post →
Vega Shah
@dr_alphalyrae · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 18,692 followers View post →
Sandeep Challa
@SandeepChalla15 · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 77 followers View post →
David Flores Granados
@DIFloresG · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 216 followers View post →
Mick
@MickPamorn · X

RT @tangming2005: Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 16 shares · 236 followers View post →
Ming "Tommy" Tang
@tangming2005 · X

Antibody drug conjugate: the “biological missile” for targeted cancer therapy https://t.co/WJdHFZcZq1

Feb 21, 2024 · 59 likes · 16 shares · 40,861 followers View post →
Molly20256
@Molly20186 · X

RT @ForensicPsyMD: Antibody drug conjugate: the “biological missile” for targeted cancer therapy | Signal Transduction and Targeted Therapy…

Nov 4, 2023 · 1 share · 83 followers View post →
ForensicPsyMD
@ForensicPsyMD · X

Antibody drug conjugate: the “biological missile” for targeted cancer therapy | Signal Transduction and Targeted Therapy https://t.co/FXTAiAuQEE

Nov 2, 2023 · 1 share · 361 followers View post →
sander hamburger
@sanderhamburger · X

@d_stock07734 @ABenS2060 @ATLnsider You are absolutely clueless and should stop making a complete fool if yourself, That is NOT what Daiichi's ifinatamab is about. Ifinatamab is an antibody-drug conjugate: the “biological missile” for targeted cancer therapy so in essence a direct competitor of DCVAX Stop posing BS

Oct 21, 2023 · 544 followers View post →
Creative-Biolabs
@creativebiolabs · X

Antibody drug conjugate: the “biological missile” for targeted cancer therapy. https://t.co/6l26FpwQRD

Mar 23, 2022 · 1,120 followers View post →
RADIOLOGY_papers
@BtzPapers · X

Antibody drug conjugate: the "biological missile" for targeted cancer therapy https://t.co/SoBsEox1TK

Mar 23, 2022 · 12 followers View post →